INMED PHARMACEUTICALS INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
INMED PHARMACEUTICALS INC. (INM) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of $492.45 thousand for the 12-month period ending 2025-06-30, per its S-4/A filed 2026-09-09.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-09-09
- INMED PHARMACEUTICALS INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2023 was -$553.88K.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month as first filed |
|---|---|---|
| 2025-06-30 | $492.45K S-4/A · filed 2026-09-09 | -$492.45K 10-K · filed 2025-09-23 |
| 2024-06-30 | -$123.42K S-4 · filed 2026-07-02 | |
| 2023-06-30 | -$553.88K 10-K · filed 2024-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |